About 27 % of doctors had good knowledge about the use of tPA in stroke, 36% were average (moderate), and 36% had poor knowledge, and there was variation in knowledge regarding the items of inclusion and exclusion criteria of using tPA (Table 1; Table 2; Table 3; Table 4; and Table 5). This evidence concerns the gene PLAT and Stroke.